GEN Exclusives

More »

GEN Poll

More »
Jan 26, 2012

Biodefense in 2012

The National Defense Authorization Act (NDAA) enacted by President Barack Obama on New Year’s Eve included spending limits for several biodefense programs. While the Chemical and Biological Defense Program saw its authorization trimmed by 5%, largely reflecting program delays, NDAA approved $259.5 million for the Cooperative Biological Engagement Program (CBEP). The increased budget reflects an expansion of the program’s activity and geography, moving beyond the countries of the former Soviet Union into parts of Asia and Africa. But that expansion worries the House of Representatives, which persuaded the Senate to allow CBEP only 80% of its funding pending more details on the expansion. Do you agree with CBEP’s new initiatives?

Should the Cooperative Biological Engagement Program be allowed to continue its new mission of capacity building by moving into new countries?


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »